Clinical Roundup JNCCN study sheds light on multi-organ adverse events from immunotherapy September 11, 2020Vol.46 No.34
Clinical Roundup City of Hope scientists combine oncolytic virus and CAR T in solid tumors September 11, 2020Vol.46 No.34
Clinical Roundup Phase II study of Tabrecta shows positive ORR for NSCLC September 11, 2020Vol.46 No.34
In Brief Justin Leung receives $1.9 million in funds to research DNA damage response September 11, 2020Vol.46 No.34
Letter To The Editor A reminder: The real goal is saving lives September 11, 2020Vol.46 No.34By Frances M. Visco
Guest Editorial Toward individualized breast cancer screening strategies—TMIST September 11, 2020Vol.46 No.34By Etta D. Pisano, Constantine A. Gatsonis, Peter J. O'Dwyer and Mitchell D. Schnall
Conversation with The Cancer Letter Mitch Schnall: “We don’t want to lose momentum as this review is happening” September 11, 2020Vol.46 No.34By Paul Goldberg
